Canada - English - Health Canada

pro doc limitee - enalapril maleate - tablet - 5mg - enalapril maleate 5mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

pro doc limitee - enalapril maleate - tablet - 10mg - enalapril maleate 10mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

pro doc limitee - enalapril maleate - tablet - 20mg - enalapril maleate 20mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

apotex inc - enalapril maleate - tablet - 2.5mg - enalapril maleate 2.5mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

apotex inc - enalapril maleate - tablet - 5mg - enalapril maleate 5mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

apotex inc - enalapril maleate - tablet - 10mg - enalapril maleate 10mg - angiotensin-converting enzyme inhibitors

Canada - English - Health Canada

apotex inc - enalapril maleate - tablet - 20mg - enalapril maleate 20mg - angiotensin-converting enzyme inhibitors

United States - English - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 20 mg - hypertension enalapril maleate is indicated for the treatment of hypertension. enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. heart failure enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trials for details and limitations of survival trials). asymptomatic left ventricular dysfunction in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see clinical pharmacology, heart failu

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 10 mg - hypertension enalapril maleate is indicated for the treatment of hypertension. enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. heart failure enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trials for details and limitations of survival trials). asymptomatic left ventricular dysfunction in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see clinical pharmacology, heart failu

United States - English - NLM (National Library of Medicine)

directrx - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 10 mg - hypertension enalapril maleate is indicated for the treatment of hypertension. enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. heart failure enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trials for details and limitations of survival trials). asymptomatic left ventricular dysfunction in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see clinical pharmacology, heart failu